- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01302730
Ankylosing Spondylitis and Spondyloarthritis Evaluation Tool Study
November 6, 2013 updated by: Eswar Krishnan, Stanford University
A Self-Administered Questionnaire for Early Detection of Axial Spondyloarthritis
This study aims to test whether a new instrument (questionnaire) is useful for identifying patients with ankylosing spondylitis.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
490
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Stanford, California, United States, 94304
- Stanford University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
All patients referred to rheumatologist office will be potentially eligible.
Description
Inclusion Criteria:
- Ability to provide informed consent
Exclusion Criteria:
- Inability to provide informed consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Physician diagnosis of Ankylosing Spondylitis
Time Frame: 6 months
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Eswar Krishnan, Stanford University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2011
Primary Completion (Actual)
March 1, 2012
Study Completion (Actual)
November 1, 2013
Study Registration Dates
First Submitted
February 22, 2011
First Submitted That Met QC Criteria
February 23, 2011
First Posted (Estimate)
February 24, 2011
Study Record Updates
Last Update Posted (Estimate)
November 8, 2013
Last Update Submitted That Met QC Criteria
November 6, 2013
Last Verified
November 1, 2013
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STANIRB-20278
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Spondylarthritis
-
University Hospital, GhentJanssen Biologics B.V.Completed
-
AbbVieActive, not recruitingAxial Spondylarthritis (axSpA)Argentina, Australia, Belgium, Bulgaria, Canada, France, Greece, Hungary, Israel, Kuwait, Mexico, Poland, Russian Federation, Spain, Switzerland, United Arab Emirates
-
CHU de ReimsUnknown
-
AbbVieRecruitingAxial Spondylarthritis (r-axSpA)Germany
-
Spanish Clinical Pharmacology SocietySpanish reumatology SocietyCompleted
-
University of LeedsCentocor, Inc.Terminated
-
PfizerCompleted
-
Centre Hospitalier Universitaire de NīmesAssistance Publique Hopitaux De Marseille; University Hospital, MontpellierRecruiting
-
Assistance Publique Hopitaux De MarseilleCompletedSpondylarthritisFrance
-
Centre Hospitalier Universitaire de NīmesCompleted